Designed to supply the Company’s Korova brand with premium, high-potency strains, the state-of-the-art facility has numerous technological improvements over prior cultivation operations. The building contains four flower rooms with sixty lights each and is expected to yield more than 3,500 pounds per year of expertly crafted cannabis flower. “This is an important building block towards building one of the dominant west coast cannabis companies […]

Unlike most other industries, in science it helps to work with your friends – that’s a quote from Dr. Jonathan Rothbard, CSO of 180 Life Sciences (NASDAQ:ATNF), who joins the podcast with ATNF co-founder Prof Sir Marc Feldmann, who co-founded the company with Professor Raphael Mechoulam (known for his discovery of tetrahydrocannabinol (THC), the psychoactive part […]

While most cell therapies in development modify DNA, Cartesian Therapeutics is focused on using their RNA Armory technology to create cell therapies for various autoimmune, oncologic, and respiratory indications. The company recently announced data from their phase 1b/2a trial (NCT04146051) of Descartes-08, an mRNA-modified CAR T-cell therapy product, in myasthenia gravis (MG). Data showed improvements […]